1 |
Sheppard, R. 2003. The fluorenylmethoxycarbonyl group in solid phase synthesis. J. Pept. Sci. 9: 545-552.
DOI
ScienceOn
|
2 |
White, T. C., K. A. Marr, and R. A. Bowden. 1998. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11: 382-402.
|
3 |
Niimi, M., N. A. Firth, and R. D. Cannon. 2010. Antifungal drug resistance of oral fungi. Odontology 98: 15-25.
DOI
ScienceOn
|
4 |
Lee, J. and D. G. Lee. 2008. Structure-antimicrobial activity relationship between pleurocidin and its enantiomer. Exp. Mol. Med. 40: 370-376.
DOI
ScienceOn
|
5 |
Perea, S., J. L. López-Ribot, W. R. Kirkpatrick, R. K. McAtee, R. A. Santillán, M. Martínez, D. Calabrese, D. Sanglard, and T. F. Patterson. 2001. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 45: 2676-2684.
DOI
ScienceOn
|
6 |
Sung, W. S., I. S. Lee, and D. G. Lee. 2007. Damage to the cytoplasmic membrane and cell death caused by lycopene in Candida albicans. J. Microbiol. Biotechnol. 17: 1797-1804.
과학기술학회마을
|
7 |
Urban, E., E. Nagy, T. Pál, A. Sonnevend, and J. M. Conlon. 2007. Activities of four frog skin-derived antimicrobial peptides (temporin-1DRa, temporin-1Va and the melittin-related peptides AR-23 and RV-23) against anaerobic bacteria. Int. J. Antimicrob. Agents 29: 317-321.
DOI
ScienceOn
|
8 |
Merrifield, B. 1986. Solid phase synthesis. Science 232: 341-347.
DOI
|
9 |
Lee, J., H. J. Hong, J. K. Kim, J. S. Hwang, Y. Kim, and D. G. Lee. 2009. A novel antifungal analog peptide derived from protaetiamycine. Mol. Cells 28: 473-477.
DOI
ScienceOn
|
10 |
Lee, M. K., H. K. Kim, T. Y. Lee, K. S. Hahm, and K. L. Kim. 2006. Structure-activity relationships of anti-HIV-1 peptides with disulfide linkage between D- and L-cysteine at positions i and i+3, respectively, derived from HIV-1 gp41 C-peptide. Exp. Mol. Med. 38: 18-26.
DOI
|
11 |
Dathe, M. and T. Wieprecht. 1999. Structural features of helical antimicrobial peptides: Their potential to modulate activity on model membranes and biological cells. Biochim. Biophys. Acta Biomembr. 1462: 71-87.
DOI
ScienceOn
|
12 |
Hartsel, S. and J. Bolard. 1996. Amphotericin B: New life for an old drug. Trends Pharmacol. Sci. 17: 445-449.
DOI
ScienceOn
|
13 |
Kim, K. J., W. S. Sung, S. K. Moon, J. S. Choi, J. G. Kim, and D. G. Lee. 2008. Antifungal effect of silver nanoparticles on dermatophytes. J. Microbiol. Biotechnol. 18: 1482-1484.
과학기술학회마을
|
14 |
Kontoyiannis, D. P. and R. E. Lewis. 2002. Antifungal drug resistance of pathogenic fungi. Lancet 359: 1135-1144.
DOI
ScienceOn
|
15 |
Amichai, B. and M. H. Grunwald. 1998. Adverse drug reactions of the new oral antifungal agents - terbinafine, fluconazole, and itraconazole. Int. J. Dermatol. 37: 410-415.
DOI
ScienceOn
|
16 |
Cole, A. M., P. Weis, and G. Diamond. 1997. Isolation and characterization of pleurocidin, an antimicrobial peptide in the skin secretions of winter flounder. J. Biol. Chem. 272: 12008-12013.
DOI
ScienceOn
|
17 |
Albertson, G. D., M. Niimi, R. D. Cannon, and H. F. Jenkinson. 1996. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob. Agents Chemother. 40: 2835-2841.
|
18 |
Habermann, E. 1972. Bee and wasp venoms. Science 177: 314-322.
DOI
|